New Hair Loss Drug Shows 80% Success in Clinical Trial

A breakthrough drug for alopecia areata helped 40% of patients regrow hair covering 80% of their scalp, exceeding expectations and sending Q32 Bio's stock soaring.

After financial struggles and layoffs, the company's bet on bempikibart is paying off for millions living with autoimmune hair loss.